dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:21:01Z
dc.date.available2014-05-27T11:21:01Z
dc.date.created2014-05-27T11:21:01Z
dc.date.issued2004-01-01
dc.identifierPesquisa odontologica brasileira = Brazilian oral research, v. 18, n. 1, p. 80-84, 2004.
dc.identifier1806-8324
dc.identifierhttp://hdl.handle.net/11449/67609
dc.identifier10.1590/S1806-83242004000100015
dc.identifierS1806-83242004000100015
dc.identifier2-s2.0-16644365235
dc.identifier2-s2.0-16644365235.pdf
dc.identifier0053567153623569
dc.identifier6543563161403421
dc.identifier0000-0002-2416-2173
dc.description.abstractSuperinfection by Candida can be refractory to conventional periodontal treatments in specific situations, such as in immunocompromised patients. In these cases, the systemic therapy with antifungal drugs could be indicated. The aim of this study was to analyse antifungal susceptibility of Candida spp. strains isolated from chronic periodontitis patients and from control individuals. A total of 39 C. albicans isolates, 9 C. tropicalis, 2 C. glabrata and 5 Candida spp. from control individuals and 30 C. albicans, 3 C. tropicalis and 2 C. glabrata from periodontitis patients were tested. In the control group, 1 isolate of C. glabrata was resistant to ketoconazole and 1 Candida spp. was resistant to amphotericin B, ketoconazole and miconazole. Among the isolates of periodontitis group, 1 (3.33%) C. albicans isolate was resistant to flucytosine and ketoconazole. According to the obtained results, it could be concluded that fluconazole was the most effective drug against the several Candida species studied. There were not expressive differences in the susceptibility of isolates from periodontitis patients or from control individuals.
dc.languageeng
dc.relationPesquisa Odontológica Brasileira = Brazilian Oral Research
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectantifungal agent
dc.subjectfluconazole
dc.subjectflucytosine
dc.subjectketoconazole
dc.subjectmiconazole
dc.subjectadult
dc.subjectCandida
dc.subjectcase control study
dc.subjectdrug effect
dc.subjecthuman
dc.subjectisolation and purification
dc.subjectmicrobiological examination
dc.subjectmicrobiology
dc.subjectmiddle aged
dc.subjectperiodontitis
dc.subjectAdult
dc.subjectAntifungal Agents
dc.subjectCase-Control Studies
dc.subjectFluconazole
dc.subjectFlucytosine
dc.subjectHumans
dc.subjectKetoconazole
dc.subjectMiconazole
dc.subjectMicrobial Sensitivity Tests
dc.subjectMiddle Aged
dc.subjectPeriodontitis
dc.titleIn vitro antifungal susceptibility of Candida spp. isolates from patients with chronic periodontitis and from control patients
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución